25 May 2013
Keywords: bayer, signs, deal, prostrakan, tostrex, germany-based, schering
Article | 15 December 2008
Germany-based Bayer Schering Pharma has signed an agreement to develop and commercialize Scottish drugmaker ProStrakan's Tostrex in Canada, Latin America, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.